MoneyWorks4Me

Akums Drugs and Pharmaceuticals informs about analyst meet

27 May 2025 Evaluate
Akums Drugs and Pharmaceuticals has informed that pursuant to regulation 30 read with Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals will be interacting with the Analysts / Investors, details of the meetings are enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1794.35
Dr. Reddys Labs. 1197.45
Cipla 1328.70
Lupin 2009.15
Zydus Lifesciences 1142.25
View more..